Loncar China BioPharma ETF (CHNA): Price and Financial Metrics ETF
CHNA Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
| Current price | $13.53 | 52-week high | $22.89 |
| Prev. close | $13.54 | 52-week low | $13.35 |
| Day low | $13.53 | Volume | 100 |
| Day high | $13.53 | Avg. volume | 538 |
| 50-day MA | $14.52 | Dividend yield | 0.5% |
| 200-day MA | $17.26 |
CHNA Stock Price Chart Interactive Chart >
Loncar China BioPharma ETF (CHNA) ETF Bio
The investment objective of the Loncar China BioPharma ETF seeks to track an index built by Loncar that measures the performance of Chinese pharmaceutical and biotech companies. The index gets going by sifting out every biotech and pharma company listed on Nasdaq or the Hong Kong Stock Exchange. Companies that fall within those sectors in Loncar’s judgment are then “screened to eliminate those that focus strictly on manufacturing active pharmaceutical ingredients".
CHNA ETF Info
| Issuer | |
| Expense Ratio | % |
| Asset Class | |
| Sector | China Equities ETFs |
| Assets Under Management (AUM) | N/A |
| Net Asset Value (NAV) | $0.00 |
| Options? | No |
| Total Holdings | 89 |
CHNA Top Holdings
| Symbol | Company | % of Total |
| PNT | POINT BIOPHARMA GLOBAL INC | 0.02% |
| MRTX | MIRATI THERAPEUTICS INC | 0.02% |
| RAIN | RAIN ONCOLOGY INC | 0.02% |
| HCM | HUTCHMED CHINA-ADR | 0.02% |
| NUVL | NUVALENT INC-A | 0.01% |
| ZYME | ZYMEWORKS INC | 0.01% |
| SGEN | SEAGEN INC | 0.01% |
| YMAB | Y-MABS THERAPEUTICS INC | 0.01% |
| EQRX | EQRX INC | 0.01% |
| EXAI | EXSCIENTIA PLC | 0.01% |
CHNA Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | -25.28% |
| 3-year | -62.58% |
| 5-year | -34.88% |
| YTD | N/A |
| 2023 | 0.00% |
| 2022 | -29.85% |
| 2021 | -8.23% |
| 2020 | 31.94% |
| 2019 | 29.50% |
CHNA Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||